Skip to main content
Equibles

BARCLAYS PLC

Position in NXTC — NextCure, Inc.

CIK 312069 LONDON, X0
Back to NXTC Full portfolio

Position in NXTC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,161
-$50,924 QoQ
Shares Held
5,726
+1.8% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. NXTC ranks #326 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in NXTC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,161 5,726
2026-03-31 $60,085 5,626
2025-12-31 $79,832 5,626
2025-09-30 $32,968 5,626
2025-06-30 $31,058 67,518
2025-03-31 $32,408 67,518
2024-12-31 $52,056 67,518
2024-09-30 $92,499 67,518
2024-06-30 $107,353 67,518
2024-03-31 $150,632 67,548
2023-12-31 $77,004 67,548
2023-09-30 $87,136 67,548
2023-06-30 $121,586 67,548
2023-03-31 $99,971 67,548
2022-12-31 $95,259 67,560
2022-09-30 $187,244 68,089
2022-06-30 $320,018 68,089
2022-03-31 $354,225 72,886
2021-12-31 $431,735 71,956
2021-09-30 $501,219 74,365
2021-06-30 $308,849 38,462
2021-03-31 $381,170 38,079
2020-12-31 $474,705 43,551
2020-09-30 $408,416 46,411
2020-06-30 $213,026 9,936
2020-03-31 $216,599 5,843